Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 April 2022 | Story Lacea Loader
NSFAS

The National Student Financial Aid Scheme (NSFAS) confirmed in a circular this week that monies will be paid to universities on 8 April 2022.

This will be the first payment that the University of the Free State (UFS) receives from NSFAS this year, as per the media statement by the Minister of Higher Education, Science and Innovation, Dr Blade Nzimande.

So far this year, the UFS management has made several concessions to students to alleviate their financial pressure while waiting for their NSFAS subsidies to be released.

This week, the university management – through active engagements and input from the Institutional Student Representative Council (ISRC) – agreed on the following process for book and meal allowances to be transferred to students’ bank accounts at the earliest possible opportunity:

  1. As in the past, the services of Fundi will be used to pay the allowances to students.
  2. Fundi will inform the recipients of monies received for them.
  3. After the banking details of students have been validated, monies are transferred to a student’s bank account. Fundi will inform students whose banking details are incorrect to rectify it on the Fundi website.
  4. Students who have not received payments before, will be requested to upload their banking details on the Fundi website, after which payment will be made.

It is anticipated that students whose bank accounts are with Standard Bank will receive notice of the payment of their allowance as soon as Friday, 8 April 2022.

Students banking with other banks will receive their payments subject to the inter-banking money transfer policies of the different banks, but not later than two business days after payment.

What students must do:

  1. Ensure that you upload the correct banking details.
  2. Upload your OWN banking details, not the banking details of friends or family.
  3. Ensure that your cellphone number is correct and active on PeopleSoft.
  4. Respond as quickly as possible to SMSes received from Fundi.

The university management would like to thank the majority of students for their patience during this difficult time while waiting for the NSFAS subsidies to be released.


Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept